Howard Hughes Medical Institute’s Micron Technology MU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31M Buy
15,704
+15,463
+6,416% +$6.06M 1.28% 13
2025
Q4
$68.8K Buy
241
+1
+0.4% +$229 0.04% 29
2025
Q3
$40.2K Hold
240
0.02% 52
2025
Q2
$29.6K Buy
+240
New +$22.4K 0.01% 76
2017
Q3
Sell
-9,677
Closed -$289K 92
2017
Q2
$289K Buy
+9,677
New +$283K 0.05% 117
2016
Q1
Sell
-75,777
Closed -$1.07M 185
2015
Q4
$1.07M Sell
75,777
-133,020
-64% -$2.13M 0.16% 69
2015
Q3
$3.13M Buy
208,797
+503
+0.2% +$8.65K 0.59% 33
2015
Q2
$3.92M Buy
208,294
+26,497
+15% +$706K 0.83% 33
2015
Q1
$4.93M Buy
181,797
+44,975
+33% +$1.34M 0.67% 26
2014
Q4
$4.79M Buy
136,822
+24,357
+22% +$806K 1.28% 25
2014
Q3
$3.85M Buy
112,465
+47,534
+73% +$1.54M 0.86% 30
2014
Q2
$2.14M Buy
64,931
+9,167
+16% +$250K 0.36% 31
2014
Q1
$1.32M Buy
55,764
+52,914
+1,857% +$1.26M 0.19% 35
2013
Q4
$62K Buy
+2,850
New +$55.4K 0.01% 153

Other funds holding MU

Howard Hughes Medical Institute's MU Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Micron Technology (MU) stake by 6,416% in Q1 2026, buying an estimated $6.06M and bringing the position to 15,704 shares worth $5.31M. The position accounts for 1.28% of the portfolio, ranked #13.

Howard Hughes Medical Institute first reported a position in MU in Q4 2013 and has held it in 14 quarters since. 2,997 funds tracked by Wall St. Rank hold MU as of Q1 2026.

  • Howard Hughes Medical Institute held 15,704 shares of Micron Technology worth $5.31M as of Q1 2026.
  • Howard Hughes Medical Institute bought 15,463 Micron Technology shares in Q1 2026, an estimated $6.06M.
  • Micron Technology made up 1.28% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #13 holding.
  • Howard Hughes Medical Institute first reported a position in Micron Technology in Q4 2013 and has held it in 14 quarters since.
  • 2,997 funds tracked by Wall St. Rank held Micron Technology as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.